Search Results 121-130 of 16683 for Imiglucerase

  1. Amylase/lipase/pancrelipase/protease (oral route) - Side effects & dosage - Mayo Clinic

    Pancrelipase is used to treat patients who cannot digest food normally because their pancreas does not make enough enzymes (exocrine pancreatic insufficiency).

  2. Drugs and Supplements that Start with Y - Mayo Clinic

    Explore a comprehensive list of prescription and over-the-counter medications starting with the letter “Y” to learn about drug side effects, proper use and ...

  3. To Assess Safety, Tolerability and Efficacy of LJN452 in Patients With Primary Bile Acid Diarrhea. - Mayo Clinic

    The purpose of this study is to determine whether LJN452 improves the symptoms of bile acid diarrhea and to assess its safety and tolerability profile in ...

  4. Digestive Diseases Clinical Trials - Medical Professionals

    The purpose of this study is to develop a biorepository of blood samples from cancer patients participating in the Gemini (IRB 19-006717) protocol.

  5. Digestive Diseases Clinical Trials - Medical Professionals

    Rochester, Minn. This is a survey study to describe how women with Lynch syndrome are being screened for gynecologic cancer risk, their perception of cancer ...

  6. A Study of Seladelpar in Subjects with Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA) - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  7. Pemigatinib (oral route) - Side effects & dosage - Mayo Clinic

    Pemigatinib is also used to treat myeloid/lymphoid neoplasms (blood cancer) that has come back or did not respond to treatment in patients who have a certain ...

  8. Glucarpidase After High-Dose Methotrexate in Patients With Osteosarcoma - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  9. My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors - Mayo Clinic

    This multicenter, non-randomized, open-label study will evaluate the efficacy and safety of six treatment regimens in participants with advanced solid tumors ...

  10. Efficacy and Safety Study of Mepolizumab in Subjects With Severe Hypereosinophilic Syndrome (HES) - Mayo Clinic

    About this study. Mepolizumab is a humanized monoclonal antibody. In conditions where eosinophilia is considered to play an important part in the pathology, ...